# Palladio Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/palladio-biosciences

- Industry: Biotechnology
- Headquarters: Horsham, US
- Website: www.palladiobio.com
- Total disclosed funding: $20M
- Latest round: Series B (Sep 25, 2020)
- Investors on record: 4

## About

Established in 2015 and based in Pennsylvania, US, Palladio Biosciences develops a novel therapeutics designed to offer medicines for orphan drug diseases of the kidney.

## Funding rounds

- Series B, Sep 25, 2020, $20M — OUP (Osage University Partners), Roche Venture Fund, Medicxi, Samsara BioCapital
- Series A, May 23, 2017 — Medicxi

## Investors

- Medicxi (https://capitalatlas.ai/funds/medicxi) — Series A, Series B
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series B
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series B
- Samsara BioCapital (https://capitalatlas.ai/funds/samsara-biocapital) — Series B